FBIOX vs. XBI
Compare and contrast key facts about Fidelity Select Biotechnology Portfolio (FBIOX) and SPDR S&P Biotech ETF (XBI).
FBIOX is managed by Fidelity. It was launched on Dec 16, 1985. XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FBIOX or XBI.
Correlation
The correlation between FBIOX and XBI is 0.61, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
FBIOX vs. XBI - Performance Comparison
Key characteristics
FBIOX:
0.28
XBI:
-0.02
FBIOX:
0.52
XBI:
0.16
FBIOX:
1.07
XBI:
1.02
FBIOX:
0.14
XBI:
-0.01
FBIOX:
0.61
XBI:
-0.04
FBIOX:
10.26%
XBI:
11.16%
FBIOX:
22.76%
XBI:
26.84%
FBIOX:
-71.96%
XBI:
-63.89%
FBIOX:
-36.88%
XBI:
-52.23%
Returns By Period
In the year-to-date period, FBIOX achieves a -2.59% return, which is significantly higher than XBI's -7.89% return. Over the past 10 years, FBIOX has underperformed XBI with an annualized return of -2.15%, while XBI has yielded a comparatively higher 1.73% annualized return.
FBIOX
-2.59%
-1.23%
-13.48%
5.67%
-1.40%
-2.15%
XBI
-7.89%
2.28%
-15.71%
-1.83%
-1.73%
1.73%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBIOX vs. XBI - Expense Ratio Comparison
FBIOX has a 0.69% expense ratio, which is higher than XBI's 0.35% expense ratio.
Risk-Adjusted Performance
FBIOX vs. XBI — Risk-Adjusted Performance Rank
FBIOX
XBI
FBIOX vs. XBI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Biotechnology Portfolio (FBIOX) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FBIOX vs. XBI - Dividend Comparison
FBIOX's dividend yield for the trailing twelve months is around 0.90%, more than XBI's 0.17% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBIOX Fidelity Select Biotechnology Portfolio | 0.90% | 1.21% | 0.45% | 0.00% | 0.17% | 0.26% | 0.15% | 0.00% | 0.00% | 0.00% | 6.71% | 10.77% |
XBI SPDR S&P Biotech ETF | 0.17% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% | 1.07% |
Drawdowns
FBIOX vs. XBI - Drawdown Comparison
The maximum FBIOX drawdown since its inception was -71.96%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for FBIOX and XBI. For additional features, visit the drawdowns tool.
Volatility
FBIOX vs. XBI - Volatility Comparison
The current volatility for Fidelity Select Biotechnology Portfolio (FBIOX) is 12.31%, while SPDR S&P Biotech ETF (XBI) has a volatility of 14.69%. This indicates that FBIOX experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.